Table 1.
Clinical Characteristics of the Reported HCC Scalp and Skull Metastasis
No. | Reference | Year | Age | Sex | Risk Factor | Manifestation | Primary Lesion | Vascular Invasion | Skull Spread | Involvement | Other Spread | Management | Follow-Up | Prognosis |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Sanders et al40 | 2020 | 77 | F | HBV | Scalp mass | Multiple, infiltrative | None | Frontal region | Scalp, skull | None | BSC | 2 months | Expired |
2 | Sadik et al41 | 2019 | 54 | M | HCV | Scalp mass | Single | IVC, RAT | Superior sagittal sinus | Scalp, skull | Lung, rib | Craniotomy | 26 days | Expired |
3 | Han et a25 | 2017 | 66 | M | S.J. | Scalp mass, headache, dizziness | None | None | Left occipital region | Scalp, skull, dura | None | Selective embolization, craniotomy | 9 months | Alive |
4 | Ferraz et al42 | 2016 | 55 | M | None | Scalp mass with local pain | Single, infiltrative | None | Right frontal region | Scalp, skull | Clavicle, sternum, hip, lumbar spine | Craniotomy, radiotherapy | 6 months | Expired |
5 | Kim et al43 | 2015 | 41 | M | ND | Sudden headache, vomiting, drowsiness | Multiple | ND | Right occipital region | Skull, epi-dura | Ribs, pelvis | BSC | 4 months | Expired |
6 | Subasinghe et al44 | 2015 | 56 | M | None | Scalp mass | Single | None | Occipital region | Scalp, skull | Left scapula | Excision of the scalp mass, RFA for liver mass | ND | ND |
7 | Susheela et al45 | 2015 | 40 | M | HBV | Scalp mass | Multiple | ND | Frontal region | Scalp, skull | Lung, dorsal vertebrae | Radiotherapy, sorafenib | 12 months | Expired |
8 | Chye et al46 | 2015 | 69 | F | HCV | Headache, nausea, vomiting, dizziness | Single | None | Left temporal region | Scalp, skull, epi-dura, dura | None | Radiotherapy for brain, TACE for liver mass | ND | ND |
9 | Guo et al47 | 2014 | 49 | M | HBV | Scalp mass | Single | None | Right parietal-occipital region | Scalp, skull | None | Craniotomy, TACE for liver mass | 18 months | Expired |
10 | Azarpira et al48 | 2014 | 38 | M | HBV | Scalp mass | None | None | Right temporal region | Scalp, skull, dura | None | Radiotherapy, chemotherapy | 3 months | Alive |
11 | Turan et al49 | 2013 | 70 | M | HBV | Scalp mass | Single | None | Frontal region | Scalp, skull | Lung, adrenal glands, ribs, lumbar vertebrae, and pelvis | Craniotomy, sorafenib | 11 months | Expired |
12 | Brunetti et al50 | 2012 | 79 | M | ND | Scalp mass | Multiple | ND | Parietal-occipital region | Scalp, skull | Mandible | Biopsy | ND | ND |
13 | Ermis et al51 | 2012 | 72 | M | HCV | Scalp mass | Multiple | PVTT | Right frontal-parietal region | Scalp, skull | Thoracic vertebrae, ribs, sternum, right sacroiliac joint | Biopsy | ND | ND |
14 | Goto et al52 | 2010 | 56 | M | HBV | Scalp mass | Multiple | None | Left occipital-temporal region | Scalp, skull | Thoracic vertebrae | Radiotherapy for brain, TACE for liver mass | ND | Expired |
15 | Woo et al53 | 2010 | 46 | M | ND | Severe headache, unconsciousness | ND | ND | Right temporal region | Skull, epi-dura, dura | ND | Craniotomy | 5 days | Expired |
16 | Fukushima et al26 | 2010 | 58 | M | ND | Scalp mass | None | None | Left temporal region | Scalp, skull | None | Craniotomy | ND | ND |
17 | Kanai et al54 | 2009 | 56 | M | HCV | Severe headache, unconsciousness | Single, huge | None | Left occipital region | Scalp, skull, epi-dura | ND | Craniotomy | 21 days | Expired |
18 | Shim et al55 | 2008 | 71 | M | HCV, alcohol | Scalp mass | Two | None | Occipital region | Scalp, skull | None | Craniotomy, | 9 months | Alive |
TACE for liver mass | ||||||||||||||
19 | Hsu et al56 | 2008 | 53 | M | HBV | Scalp mass, visual field defect | Multiple | None | Left parietal-occipital region | Scalp, skull, epi-dura | None | TACE, craniotomy, radiotherapy | 10 months | Alive |
20 | Hsieh et al57 | 2006 | 46 | M | HBV | Scalp mass | None | None | Left frontal region | Scalp, skull | Spine, left femur | Craniotomy, radiotherapy, chemotherapy | 15 months | Alive |
21 | Simone et al30 | 2005 | 61 | M | HCV | Scalp mass | Multiple | None | Left parietal region | Scalp, skull | Sternum, lung | Craniotomy, chemotherapy | ND | ND |
22 | Nam et al58 | 2005 | 65 | M | HCV, alcohol | Scalp mass | Multiple | None | Frontal region | Scalp, skull, dura | Sternum, ribs | Biopsy, radiotherapy | 26 months | Alive |
23 | Jegou et al59 | 2004 | 55 | M | ND | Scalp mass | Single | None | Left frontal region | Scalp, skull | Adrenal gland | Biopsy | ND | ND |
24 | Chan et al60 | 2004 | 75 | F | None | Scalp mass | Single | None | Right frontal region | Scalp, skull | None | Craniotomy | ND | ND |
25 | Torres et al61 | 2002 | 66 | F | HCV | Scalp mass | Two | None | Occipital region | Scalp, skull | None | Biopsy | 42 days | Expired |
26 | Hayashi et al62 | 2000 | 70 | M | ND | Left-sided hemiparesis | ND | ND | Right parietal region | Scalp, skull, epi-dura | ND | Craniotomy | 2 months | Expired |
27 | Nakagawa et al63 | 1992 | 52 | M | ND | ND | ND | ND | ND | Scalp, skull, epi-dura | ND | Craniotomy | ND | Expired |
Abbreviations: F, female; M, male; ND, not described; BSC, best supportive care; IVC, inferior vena cava; RFA, radiofrequency ablation; PVTT, portal vein tumor thrombus; S.J., Schistosoma japonicum; RAT, right atrium thrombus.